News

News

ImmPACT Bio Closes $111 Million Series B Financing, Names New Board Chair and New President and CEO, and Updates on Phase 1 Clinical Study in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Read full story

Iterative Scopes Announces $150 Million Series B to Advance AI-Driven Precision Medicine for Gastroenterology

Read full story
Partner news

Leyden Labs Licenses Pan-Influenza Antibody from Janssen

Read full story
Partner news

The UK’s largest ever health research programme to transform the prevention, detection and treatment of diseases

Read full story

Digital Health Leader Verana Health Secures $150M Series E Funding Round

Read full story

AviadoBioTM Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform

Read full story

DePuy Synthes Announces Acquisition of OrthoSpin

Read full story

On Target Laboratories Announces FDA Approval of CYTALUX™ (pafolacianine) injection for Identification of Ovarian Cancer During Surgery

Read full story
Partner news

Philogen announces new collaboration with Janssen to discover small molecule therapeutics

Read full story
Partner news

Ultromics Announces Collaboration with Janssen to Develop AI for Patients with Amyloidosis with Cardiac Involvement

Read full story
Partner news

F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics

Read full story
JNJ Press releases

Johnson & Johnson Innovation becomes a leading partner of Sitem Startup Club

Read full story
In the media

Janssen on driving R&D innovation with data science

Read full story
Partner news

Whole Genome Sequencing data on 200,000 UK Biobank participants are made widely available for research

Read full story

CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes

Read full story